Market Research Reports

  Next-generation sequencing (NGS) provides sequence profiling from transcriptomes and genome to deoxyribonucleic acid (DNA)-protein interactions. The technologies used in the workflow of sequencing are an integral part of research and discovery in biology.  The increasing number of new cancer cases across the globe, favorable regulatory and reimbursement scenarios for NGS-based tests in the U.S. and increasing focus of key market players on developing NGS-based products for cancer and noninvasive prenatal testing (NIPT). Moreover, next-generation sequencing techniques are widely used for the diagnosis of genetic diseases. The increasingly widespread use of NGS in diagnostic laboratories has enhanced the accuracy of genetic diagnostics with high consistency. As per BIS Research analysis the NGS sample preparation market is expected to witness robust growth. The market growth for NGS sample preparation is attributed to the use of NGS sample preparation in medical science, w...

 The growth of the NGS sample preparation market is expected to be driven by the widespread use of NGS in diagnostic laboratories, which has enhanced the accuracy of genetic diagnostics with high consistency. Advanced genetic diagnostic techniques are being used for predictive genetic testing and prenatal diagnosis. As the number of people suffering from genetic disorders is increasing, the efficiency and consistency of the diagnostic screening tests are becoming more crucial. Faster results with minimum errors are required to effectively screen a genetic disorder. The automated NGS sample preparation enhances the consistency and throughput of sample preparation for genetic sequencing. The current market for NGS sample preparation is majorly dominated by manufacturers and service providers such as Thermo Fisher Scientific Inc, Illumina, Inc., BGI Group, Agilent Technologies, Inc., Aurora Biomed, Inc., F. Hoffmann-La Roche Ltd, OPENTRONS, Promega Corporation, Qiagen N.V., Bio-Rad La...